| Trial ID: | L0378 |
| Source ID: | NCT00124098
|
| Associated Drug: |
Aranesp® (Darbepoetin Alfa)
|
| Title: |
An Evaluation of Aranesp® in Subjects With Anaemic Chronic Kidney Disease (CKD)
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Kidney Disease
|
| Interventions: |
DRUG: Aranesp® (darbepoetin alfa)
|
| Outcome Measures: |
Primary: Haemoglobin level | Secondary: Aranesp® doses|Adverse events|Laboratory parameters|Blood pressure
|
| Sponsor/Collaborators: |
Sponsor: Amgen
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2008-06-16
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00124098
|
